Hennion & Walsh Asset Management, Inc.

Position in IMVT — Immunovant, Inc.

CIK 1861642 Parsippany, NJ

Position in IMVT

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$4,650,031

+$2,389,368 QoQ

Shares Held

120,686

+32.6% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#59

of 226 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. IMVT ranks #14 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	48,019	$11,571,138
2	CELC	Celcuity Inc.	100,368	$10,500,500
3	URGN	UroGen Pharma Ltd.	276,696	$10,182,412
4	TVTX	Travere Therapeutics, Inc.	171,470	$9,741,210
5	SNDX	Syndax Pharmaceuticals Inc	342,883	$7,495,422
6	QURE	uniQure N.V.	142,113	$6,545,724
7	KURA	Kura Oncology, Inc.	568,845	$6,240,229
8	ARDX	Ardelyx, Inc.	1,211,690	$6,179,619

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,650,031	120,686	+32.6%	Shares	Sole	2026-07-08
2026-03-31	$2,260,663	91,009	+26.9%	Shares	Sole	2026-05-13
2025-12-31	$1,822,741	71,705	-49.9%	Shares	Sole	2026-01-14
2023-09-30	$5,492,841	143,080	-16.5%	Shares	Sole	2023-10-27
2023-06-30	$3,250,092	171,328	-24.7%	Shares	Sole	2023-08-09
2023-03-31	$3,529,393	227,556	-10.3%	Shares	Sole	2023-04-20
2022-12-31	$4,502,039	253,636	+10.4%	Shares	Sole	2023-01-12
2022-09-30	$1,281,586	229,675	-2.7%	Shares	Sole	2022-11-14
2022-06-30	$920,388	235,997	+6.7%	Shares	Sole	2022-07-19
2022-03-31	$1,218,459	221,136	+37.5%	Shares	Sole	2022-04-26
2021-12-31	$1,370,016	160,800	+143.1%	Shares	Sole	2022-02-14
2021-09-30	$574,773	66,142	+52.1%	Shares	Sole	2021-11-12
2021-06-30	$459,795	43,500	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.